For example, the TGF-β-mediated angiogenic effect on xenografts of prostate cancer is regulated by TGFBRII/SMAD3-dependent upregulation of fibroblast growth factor-2 (FGF2) expression and release in prostate stroma (Figure 2B) [50]. This evidence concerns the gene TGFB1 and Familial prostate cancer.